marketcaparena
Search

    BDSX

    BIODESIX INC

    Company overview

    Market capitalization
    $320.97M
    Employees
    334
    Latest publication
    2026-09-29
    About BIODESIX INC

    Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests markets as part of IQLung testing strategy, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to guide treatment decisions. In addition, the company provides diagnostic solutions, including translational research, initial biomarker discovery, assay design, development and validation, testing of clinical trial samples, regulatory, reimbursement, commercialization, and logistical support services for biopharmaceutical, life sciences, and diagnostic companies. Further, it operates laboratories. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Total Revenue26,861,000USD
    Research Development3,135,000USD
    Selling General Administrative24,282,000USD
    Total Operating Expenses32,249,000USD
    Operating Income-5,388,000USD
    Total Other Income Expense Net-1,885,000USD
    Interest Expense1,982,000USD
    Net Income-7,273,000USD
    SourceDisclosureDeterministicFinal

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets95,326,000USD94,637,000USD87,476,000USD88,722,000USD87,740,000USD86,241,000USD97,244,000USD102,743,000USD
    Cash And Equivalents29,996,000USD———————
    Total Current Assets43,565,000USD40,912,000USD32,518,000USD33,401,000USD32,445,000USD29,622,000USD39,484,000USD44,017,000USD
    Other Current Assets4,456,000USD5,840,000USD4,495,000USD2,623,000USD4,266,000USD4,380,000USD4,636,000USD4,575,000USD
    Other Non Current Assets6,406,000USD———————
    Total Liabilities86,182,000USD———————
    Total Current Liabilities15,291,000USD14,489,000USD17,436,000USD18,152,000USD15,160,000USD13,316,000USD14,317,000USD12,963,000USD
    Other Current Liabilities906,000USD———————
    Other Non Current Liabilities704,000USD———————
    Total Stockholder Equity9,144,000USD9,132,000USD-2,465,000USD-1,722,000USD1,138,000USD11,060,000USD20,876,000USD27,857,000USD
    Total Equity Including Noncontrolling Interest9,144,000USD———————
    Deferred Revenue205,000USD———————
    Net Receivables9,113,000USD9,500,000USD9,036,000USD12,674,000USD7,451,000USD7,639,000USD8,603,000USD8,036,000USD
    Property Plant Equipment Net27,345,000USD27,380,000USD27,814,000USD30,704,000USD28,241,000USD28,929,000USD29,595,000USD30,601,000USD
    Goodwill15,031,000USD———————
    Intangible Assets2,979,000USD3,451,000USD3,883,000USD4,375,000USD4,871,000USD5,360,000USD5,874,000USD6,438,000USD
    Accounts Payable2,160,000USD3,651,000USD3,080,000USD3,617,000USD2,973,000USD2,925,000USD2,194,000USD2,537,000USD
    Short Term Debt1,609,000USD1,454,000USD1,370,000USD1,405,000USD1,248,000USD1,112,000USD740,000USD653,000USD
    Common Stock11,000USD10,000USD8,000USD8,000USD146,000USD146,000USD145,000USD145,000USD
    Retained Earnings-512,828,000USD-505,555,000USD-497,762,000USD-493,782,000USD-485,066,000USD-473,598,000USD-462,497,000USD-454,246,000USD
    Total Liab—85,505,000USD89,941,000USD90,444,000USD86,602,000USD75,181,000USD76,368,000USD74,886,000USD
    Other Current Liab—9,161,000USD12,025,000USD10,357,000USD10,322,000USD8,491,000USD10,705,000USD9,097,000USD
    Capital Stock—10,000USD8,000USD8,000USD146,000USD146,000USD145,000USD145,000USD
    Good Will—15,031,000USD15,031,000USD15,031,000USD15,031,000USD15,031,000USD15,031,000USD15,031,000USD
    Cash—25,572,000USD18,987,000USD16,704,000USD20,728,000USD17,603,000USD26,245,000USD31,406,000USD
    Cash And Short Term Investments—25,572,000USD18,987,000USD16,704,000USD20,728,000USD17,603,000USD26,245,000USD31,406,000USD
    Current Deferred Revenue—223,000USD961,000USD2,773,000USD617,000USD788,000USD678,000USD676,000USD
    Net Debt—46,038,000USD53,867,000USD56,224,000USD51,413,000USD44,682,000USD35,731,000USD30,550,000USD
    Short Long Term Debt—2,000USD6,000USD11,000USD16,000USD18,000USD21,000USD29,000USD
    Short Long Term Debt Total—71,610,000USD72,854,000USD72,928,000USD72,141,000USD62,285,000USD61,976,000USD61,956,000USD
    Long Term Debt—46,487,000USD47,445,000USD47,111,000USD46,782,000USD36,693,000USD36,408,000USD36,112,000USD
    Property Plant Equipment Gross—40,788,000USD40,330,000USD40,116,000USD39,056,000USD38,997,000USD38,729,000USD38,850,000USD
    Common Stock Shares Outstanding—9,656,000shares8,065,000shares7,500,000shares7,332,800shares7,327,350shares7,330,150shares7,314,800shares
    Non Current Assets Total—53,725,000USD54,958,000USD55,320,999USD55,295,000USD56,619,000USD59,693,000USD58,726,000USD
    Non Current Liabilities Total—71,016,000USD72,505,000USD72,292,000USD71,442,000USD61,865,000USD63,984,000USD61,923,000USD
    Non Current Liabilities Other—860,000USD1,021,000USD769,000USD549,000USD692,000USD815,000USD620,000USD
    Non Currrent Assets Other—7,863,000USD8,230,000USD5,210,999USD7,152,000USD7,299,000USD9,193,000USD6,656,000USD
    Net Working Capital—26,423,000USD15,082,000USD15,249,000USD17,285,000USD16,306,000USD25,167,000USD31,054,000USD
    Unclassified Non Current Liabilities—23,669,000USD24,039,000USD24,412,000USD24,111,000USD24,480,000USD26,761,000USD25,191,000USD
    Unclassified Equity—514,667,000USD495,281,000USD492,044,000USD485,912,000USD484,366,000USD483,083,000USD481,813,000USD
    Inventory———1,400,000USD———1,200,000USD
    Other Assets——————-1,933,000USD—
    Unclassified Current Assets———————-1,200,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets87,476,000USD97,244,000USD99,096,000USD92,906,000USD76,097,000USD121,070,000USD41,633,000USD39,057,000USD
    Intangible Assets3,883,000USD5,874,000USD7,911,000USD9,797,000USD11,617,000USD13,260,000USD15,092,000USD16,853,000USD
    Other Current Assets4,495,000USD4,636,000USD4,320,000USD3,781,000USD4,345,000USD5,510,000USD1,322,000USD1,407,000USD
    Total Liab89,941,000USD76,368,000USD94,516,000USD72,300,000USD56,370,000USD79,904,000USD270,172,000USD237,087,000USD
    Total Stockholder Equity-2,465,000USD20,876,000USD4,580,000USD20,606,000USD19,727,000USD41,166,000USD-228,539,000USD-198,030,000USD
    Other Current Liab12,025,000USD10,705,000USD29,860,000USD18,600,000USD25,429,000USD7,789,000USD7,441,000USD3,090,000USD
    Common Stock8,000USD145,000USD96,000USD78,000USD31,000USD27,000USD1,000USD1,000USD
    Capital Stock8,000USD145,000USD96,000USD78,000USD31,000USD27,000USD1,000USD1,000USD
    Retained Earnings-497,762,000USD-462,497,000USD-419,566,000USD-367,420,000USD-301,973,000USD-258,814,000USD-230,864,000USD-200,138,000USD
    Good Will15,031,000USD15,031,000USD15,031,000USD15,031,000USD15,031,000USD15,031,000USD11,631,000USD10,804,000USD
    Cash18,987,000USD26,245,000USD26,284,000USD43,088,000USD32,712,000USD62,126,000USD5,286,000USD5,914,000USD
    Cash And Short Term Investments18,987,000USD26,245,000USD26,284,000USD43,088,000USD32,712,000USD62,126,000USD5,286,000USD5,914,000USD
    Total Current Assets32,518,000USD39,484,000USD39,683,000USD53,334,000USD43,613,000USD86,140,000USD12,700,000USD9,913,000USD
    Total Current Liabilities17,436,000USD14,317,000USD33,416,000USD22,839,000USD28,960,000USD32,125,000USD22,600,000USD4,468,000USD
    Current Deferred Revenue961,000USD678,000USD324,000USD962,000USD1,850,000USD3,532,000USD1,283,000USD492,000USD
    Net Debt53,867,000USD35,731,000USD34,407,000USD-11,238,000USD-22,700,000USD-34,360,000USD30,685,000USD17,185,000USD
    Short Term Debt1,370,000USD740,000USD303,000USD1,592,000USD19,000USD11,840,000USD12,159,000USD—
    Short Long Term Debt6,000USD21,000USD51,000USD49,000USD19,000USD11,840,000USD12,159,000USD—
    Short Long Term Debt Total72,854,000USD61,976,000USD60,691,000USD31,850,000USD10,012,000USD27,766,000USD35,971,000USD23,099,000USD
    Long Term Debt47,445,000USD36,408,000USD35,225,000USD25,004,000USD9,993,000USD15,926,000USD23,812,000USD23,099,000USD
    Net Receivables9,036,000USD8,603,000USD7,679,000USD5,065,000USD3,656,000USD15,304,000USD5,292,000USD1,892,000USD
    Accounts Payable3,080,000USD2,194,000USD2,929,000USD1,685,000USD1,662,000USD8,964,000USD1,717,000USD886,000USD
    Property Plant Equipment Net27,814,000USD29,595,000USD29,612,000USD8,821,000USD4,179,000USD3,178,000USD2,120,000USD1,388,000USD
    Property Plant Equipment Gross40,330,000USD38,729,000USD35,224,000USD8,821,000USD4,179,000USD3,178,000USD2,120,000USD1,388,000USD
    Common Stock Shares Outstanding7,551,000shares6,483,500shares4,105,650shares2,105,150shares1,368,250shares4,838,000shares45,712,000shares1,327,066shares
    Non Current Assets Total54,958,000USD57,760,000USD59,413,000USD39,572,000USD32,484,000USD34,930,000USD28,933,000USD29,144,000USD
    Non Current Liabilities Total72,505,000USD62,051,000USD61,100,000USD49,461,000USD27,410,000USD47,779,000USD247,572,000USD232,619,000USD
    Non Current Liabilities Other1,021,000USD815,000USD712,000USD19,203,000USD17,417,000USD31,853,000USD29,472,000USD25,290,000USD
    Non Currrent Assets Other8,230,000USD7,260,000USD6,859,000USD5,923,000USD1,657,000USD3,461,000USD90,000USD99,000USD
    Net Working Capital15,082,000USD25,167,000USD6,267,000USD30,495,000USD14,653,000USD54,015,000USD-9,900,000USD5,445,000USD
    Unclassified Non Current Liabilities24,039,000USD24,828,000USD25,163,000USD-14,603,000USD-17,417,000USD-31,853,000USD164,487,000USD158,672,000USD
    Unclassified Equity495,281,000USD483,083,000USD423,954,000USD387,870,000USD321,638,000USD420,996,000USD196,282,000USD7,674,000USD
    Inventory——1,400,000USD1,400,000USD2,900,000USD3,200,000USD800,000USD700,000USD
    Accumulated Other Comprehensive Income——0USD0USD0USD-121,070,000USD-193,959,000USD-5,568,000USD
    Deferred Long Term Liab———654,000USD————
    Other Liab———19,203,000USD17,417,000USD31,853,000USD29,801,000USD25,558,000USD
    Other Assets———5,923,000USD1,657,000USD3,461,000USD90,000USD100,000USD
    Net Tangible Assets———-4,222,000USD-6,921,000USD12,875,000USD-255,262,000USD-225,686,000USD
    Unclassified Non Current Assets———-5,923,000USD-1,657,000USD-3,461,000USD——
    Unclassified Current Liabilities—————-11,840,000USD-12,159,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-7,793,000USD-3,980,000USD-8,716,000USD-11,468,000USD-11,101,000USD-8,251,000USD-10,258,000USD-10,808,000USD
    Depreciation1,415,000USD1,352,000USD1,378,000USD1,436,000USD1,405,000USD1,398,000USD1,417,000USD1,319,000USD
    Stock Based Compensation1,115,000USD1,075,000USD1,053,000USD1,039,000USD972,000USD1,265,000USD1,515,000USD1,218,000USD
    Other Non Cash Items381,000USD487,000USD349,000USD253,000USD861,000USD834,000USD324,000USD1,411,000USD
    Change To Account Receivables-488,000USD3,608,000USD-5,224,000USD181,000USD904,000USD-1,001,000USD1,859,000USD-325,000USD
    Change To Inventory20,000USD28,000USD10,000USD11,000USD——12,000USD—
    Change In Working Capital-5,286,000USD1,844,000USD-2,943,000USD2,172,000USD-739,000USD658,000USD-3,669,000USD-11,730,000USD
    Total Cash From Operating Activities-10,168,000USD778,000USD-8,879,000USD-6,568,000USD-8,602,000USD-4,096,000USD-10,671,000USD-18,590,000USD
    Capital Expenditures-144,000USD-149,000USD-67,000USD-51,000USD-137,000USD-884,000USD-286,000USD-1,997,000USD
    Free Cash Flow-10,312,000USD629,000USD-8,946,000USD-6,619,000USD-8,739,000USD-4,980,000USD-10,957,000USD-20,587,000USD
    Total Cashflows From Investing Activities-144,000USD-104,000USD-67,000USD-95,000USD-137,000USD-884,000USD-286,000USD-1,997,000USD
    Net Borrowings-5,000USD-5,000USD-4,000USD9,995,000USD-7,000USD-13,000USD-13,000USD—
    Total Cash From Financing Activities16,897,000USD1,709,000USD4,822,000USD9,789,000USD97,000USD-181,000USD144,000USD51,315,000USD
    Sale Purchase Of Stock354,000USD-313,000USD497,000USD—313,000USD—-5,055,000USD5,397,000USD
    Issuance Of Capital Stock17,568,000USD2,320,000USD4,687,000USD0USD313,000USD0USD-282,000USD55,000,000USD
    Change In Cash6,585,000USD2,383,000USD-4,124,000USD3,126,000USD-8,642,000USD-5,161,000USD-10,813,000USD30,728,000USD
    Begin Period Cash Flow19,075,000USD16,692,000USD20,828,000USD17,690,000USD26,332,000USD31,493,000USD42,306,000USD11,591,000USD
    End Period Cash Flow25,660,000USD19,075,000USD16,704,000USD20,816,000USD17,690,000USD26,332,000USD31,493,000USD42,319,000USD
    Other Cashflows From Investing Activities-63,000USD-18,000USD-19,000USD-44,000USD-63,000USD-45,000USD-55,000USD-71,000USD
    Other Cashflows From Financing Activities-667,000USD-292,000USD-167,000USD-206,000USD-209,000USD-175,000USD439,000USD-3,673,000USD
    Unclassified Financing Cash Flow17,215,000USD2,319,000USD4,496,000USD———4,773,000USD49,591,000USD
    Investments——-67,000USD-95,000USD-137,000USD-884,000USD-286,000USD-1,997,000USD
    Unclassified Investing Cash Flow———————2,068,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-35,265,000USD-42,931,000USD-52,146,000USD-65,447,000USD-43,159,000USD-31,350,000USD-30,726,000USD-26,166,000USD
    Depreciation5,601,000USD5,456,000USD5,507,000USD5,844,000USD3,178,000USD2,903,000USD2,793,000USD1,740,000USD
    Stock Based Compensation4,139,000USD6,638,000USD5,373,000USD5,961,000USD4,944,000USD3,709,000USD170,000USD142,000USD
    Other Non Cash Items1,920,000USD3,857,000USD7,092,000USD13,014,000USD4,328,000USD6,577,000USD7,682,000USD6,307,000USD
    Change To Account Receivables-531,000USD-1,811,000USD-4,718,000USD-1,501,000USD11,454,000USD-10,308,000USD-3,646,000USD-146,000USD
    Change To Inventory49,000USD22,000USD166,000USD906,000USD7,425,000USD-11,654,000USD17,000USD-389,000USD
    Change In Working Capital334,000USD-21,669,000USD11,304,000USD-4,344,000USD4,591,000USD-4,801,000USD-1,645,000USD253,000USD
    Total Cash From Operating Activities-23,271,000USD-48,649,000USD-22,870,000USD-44,972,000USD-28,223,000USD-21,366,000USD-21,726,000USD-17,677,000USD
    Capital Expenditures-403,000USD-3,230,000USD-23,062,000USD-3,534,000USD-2,547,000USD-2,177,000USD-1,310,000USD-617,000USD
    Free Cash Flow-23,674,000USD-51,879,000USD-45,932,000USD-48,506,000USD-30,770,000USD-23,543,000USD-23,036,000USD-18,294,000USD
    Total Cashflows From Investing Activities-403,000USD-3,440,000USD-23,062,000USD-3,534,000USD-2,547,000USD-2,927,000USD-1,872,000USD-617,000USD
    Net Borrowings9,979,000USD-51,000USD9,951,000USD16,498,000USD-15,514,000USD16,040,000USD13,044,000USD10,765,000USD
    Total Cash From Financing Activities16,417,000USD52,050,000USD29,129,000USD58,882,000USD1,262,000USD81,131,000USD22,972,000USD19,032,000USD
    Sale Purchase Of Stock497,000USD625,000USD643,000USD355,000USD328,000USD———
    Issuance Of Capital Stock7,320,000USD55,625,000USD56,888,000USD59,538,000USD16,671,000USD72,000,000USD10,000,000USD8,500,000USD
    Change In Cash-7,257,000USD-39,000USD-16,803,000USD10,376,000USD-29,508,000USD56,838,000USD-628,000USD738,000USD
    Begin Period Cash Flow26,332,000USD26,371,000USD43,174,000USD32,798,000USD62,306,000USD5,468,000USD6,114,000USD5,356,000USD
    End Period Cash Flow19,075,000USD26,332,000USD26,371,000USD43,174,000USD32,798,000USD62,306,000USD5,486,000USD6,094,000USD
    Other Cashflows From Investing Activities-144,000USD-210,000USD-143,000USD-236,000USD-306,000USD-232,000USD-106,000USD-119,000USD
    Other Cashflows From Financing Activities-1,379,000USD-3,524,000USD-8,948,000USD-17,154,000USD30,019,000USD-6,909,000USD-116,000USD31,678,000USD
    Unclassified Financing Cash Flow7,320,000USD55,000,000USD28,126,000USD59,183,000USD-13,243,000USD——-31,911,000USD
    Investments—-3,440,000USD-22,048,000USD-3,534,000USD-2,547,000USD-2,927,000USD-1,872,000USD-617,000USD
    Unclassified Investing Cash Flow—3,440,000USD22,191,000USD3,770,000USD2,853,000USD2,409,000USD1,416,000USD—
    Dividends Paid——-643,000USD—-328,000USD———
    Change To Liabilities———-1,986,000USD-9,107,000USD13,903,000USD1,984,000USD788,000USD
    Unclassified Operating Cash Flow————-2,105,000USD1,596,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30ProductDevelopment Services1,512,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductDiagnostic Tests25,349,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductDevelopment Services3,264,000USD0001193125-26-203960
    Q1 2026Quarterly · 2026-03-31ProductDiagnostic Tests22,291,000USD0001193125-26-203960
    Q4 2025Quarterly · 2025-12-31ProductDevelopment Services3,607,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductDiagnostic Tests25,148,000USDLegacy provider
    FY 2025Yearly · 2025-12-31ProductDevelopment Services9,302,000USD0001193125-26-076547
    FY 2025Yearly · 2025-12-31ProductDiagnostic Tests79,197,000USD0001193125-26-076547
    Q3 2025Quarterly · 2025-09-30ProductDevelopment Services1,933,000USD0001193125-25-262532
    Q3 2025Quarterly · 2025-09-30ProductDiagnostic Tests19,835,000USD0001193125-25-262532
    Q2 2025Quarterly · 2025-06-30ProductDevelopment Services2,120,000USD0000950170-25-105026
    Q2 2025Quarterly · 2025-06-30ProductDiagnostic Tests17,898,000USD0000950170-25-105026
    Q1 2025Quarterly · 2025-03-31ProductDevelopment Services1,642,000USD0001193125-26-203960
    Q1 2025Quarterly · 2025-03-31ProductDiagnostic Tests16,316,000USD0001193125-26-203960
    Q4 2024Quarterly · 2024-12-31ProductDevelopment Services3,224,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductDiagnostic Tests17,205,000USDLegacy provider
    FY 2024Yearly · 2024-12-31ProductDevelopment Services6,615,000USD0001193125-26-076547
    FY 2024Yearly · 2024-12-31ProductDiagnostic Tests64,708,000USD0001193125-26-076547
    Q3 2024Quarterly · 2024-09-30ProductDevelopment Services983,000USD0001193125-25-262532
    Q3 2024Quarterly · 2024-09-30ProductDiagnostic Tests17,168,000USD0001193125-25-262532
    FY 2023Yearly · 2023-12-31ProductDevelopment Services3,895,000USD0000950170-25-030835
    FY 2023Yearly · 2023-12-31ProductLung Diagnostic Testing45,192,000USD0000950170-25-030835
    FY 2022Yearly · 2022-12-31ProductBiopharma Services And Other3,674,000USD0000950170-24-023513
    FY 2022Yearly · 2022-12-31ProductDiagnostic Tests34,538,000USD0000950170-24-023513
    FY 2021Yearly · 2021-12-31ProductDiagnostic Tests48,937,000USD0000950170-23-006092
    FY 2021Yearly · 2021-12-31ProductServices5,569,000USD0000950170-23-006092
    FY 2020Yearly · 2020-12-31ProductDiagnostic Tests40,919,000USD0000950170-22-003495
    FY 2020Yearly · 2020-12-31ProductServices4,638,000USD0000950170-22-003495
    FY 2019Yearly · 2019-12-31ProductDiagnostic Tests17,315,000USD0001564590-21-013512
    FY 2019Yearly · 2019-12-31ProductServices7,237,000USD0001564590-21-013512

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.